Search Results

You are looking at 201 - 210 of 1,257 items for :

  • Refine by Access: All x
Clear All
Full access

Namrata Vijayvergia, Prashant C. Shah, and Crystal S. Denlinger

undergone invasive treatment, including surgery, radiation therapy, and/or chemotherapy, resulting in a higher comorbidity burden compared with survivors of other cancers. 5 These treatments and their effects can impact QOL, both temporarily after treatment

Full access

Charlotte E.L. Klaver, Lieke Gietelink, Willem A. Bemelman, Michel W.J.M. Wouters, Theo Wiggers, Rob A.E.M. Tollenaar, Pieter J. Tanis, and on behalf of the Dutch Surgical Colorectal Audit Group

Dutch Surgical Colorectal Audit (DSCA) has been evaluating and reporting on the quality of care of primary CRC surgery since 2009. 7 , 8 The goal of this study was to evaluate current clinical practice regarding and short-term outcomes of the treatment

Full access

Beryl McCormick

, delivered with a specially designed mobile linear accelerator using electrons, or the ELIOT technique. The dose is a single dose of 21 Gy in the experimental arm delivered at the time of breast surgery. The standard treatment arm includes postoperative WBRT

Full access

Michelle T. Ashworth and Adil Daud

result of a selection effect for patients with more indolent, oligometastatic disease or for more fit patients who can undergo surgery. This has not been evaluated in a prospective randomized clinical trial, and will continue to be a moving target as more

Full access

Martine Extermann

. 13 Marcantonio ER Goldman L Mangione CM . A clinical prediction rule for delirium after elective noncardiac surgery . JAMA 1994 ; 271 : 134 – 139 . 14 Inouye SK Viscoli CM Horwitz RI . A predictive model for delirium in

Full access

Scott M. Schuetze

: long-term results of the Rizzoli's 4th protocol . Eur J Cancer 2001 ; 37 : 2030 – 2039 . 37. Bacci G Picci P Ferrari S . Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients

Full access

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Ajjai Alva, Michael Baine, Kathryn Beckermann, Maria I. Carlo, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Arpita Desai, Yasser Ged, Saby George, John L. Gore, Naomi Haas, Steven L. Hancock, Payal Kapur, Christos Kyriakopoulos, Elaine T. Lam, Primo N. Lara, Clayton Lau, Bryan Lewis, David C. Madoff, Brandon Manley, M. Dror Michaelson, Amir Mortazavi, Lakshminarayanan Nandagopal, Elizabeth R. Plimack, Lee Ponsky, Sundhar Ramalingam, Brian Shuch, Zachary L. Smith, Jeffrey Sosman, Mary A. Dwyer, Lisa A. Gurski, and Angela Motter

% CI, 2%–16%). 26 This model was validated in an independent dataset. 28 Surgical Options for Patients With Relapsed or Stage IV Disease Patients with stage IV disease also may benefit from surgery. For example, lymph nodes suspicious for

Full access

Titilayo O. Adegboyega, Jeffrey Landercasper, Jared H. Linebarger, Jeanne M. Johnson, Jeremiah J. Andersen, Leah L. Dietrich, Collin D. Driscoll, Meghana Raghavendra, Anusha R. Madadi, Mohammed Al-Hamadani, Choua A. Vang, Kristen A. Marcou, Jane Hudak, and Ronald S. Go

emphasizing the importance of NCCN Guidelines. Since 2009, NCCN Guideline compliance has been recorded by surgeons prospectively at the point of patient contact before and after surgery using electronic synoptic templates (EST). The EST is incorporated into

Full access

Abdul-Rahman Jazieh, Hanaa Bamefleh, Ahmet Demirkazik, Rabab Mohamed Gaafar, Fady B. Geara, Mansur Javaid, Jamal Khader, Kian Khodadad, Walid Omar, Ahmed Saadeddin, Hassan Al Sabe, Mohammad Behgam Shadmehr, Amgad El Sherif, Najam Uddin, Mohammad Jahanzeb, and David Ettinger

formed. The committee comprises various experts in thoracic oncology, including medical and clinical oncology, radiation oncology, pulmonology medicine, thoracic surgery, radiology, and pathology. The committee convened twice and corresponded frequently

Full access

Shailender Bhatia and John A. Thompson

as surgery or radiation therapy, may provide palliation of symptoms caused by local tumor growth, the cornerstone of treatment for metastatic melanoma is systemic therapy to address the clinical and subclinical sites of metastases. Chemotherapeutic